Document is current

Article History

Accepted: 11 September 2020

First Online: 1 October 2020

Declarations

:

: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

: John M. Kane has been a consultant and/or advisor for or has received honoraria from Alkermes, Allergan, LB Pharmaceuticals, H. Lundbeck, Intracellular Therapies, Janssen Pharmaceuticals, Johnson and Johnson, Merck, Minerva, Neurocrine, Newron, Otsuka, Pierre Fabre, Reviva, Roche, Sumitomo Dainippon, Sunovion, Takeda, Teva, and UpToDate and is a shareholder in LB Pharmaceuticals and Vanguard Research Group. Christoph Hiemke has received speaker’s or consultancy fees from the following pharmaceutical companies: Janssen-Cilag and Servier. He is the managing director of the psiac GmbH that provides an internet-based drug–drug interaction program for psychopharmacotherapy. He reports no conflicts of interest with this publication. Ekkehard Haen received speaker’s or consultancy fees from the following pharmaceutical companies: Servier, Novartis, and Janssen-Cilag. He is a managing director of AGATE, a non-profit working group to improve drug safety and efficacy in the treatment of psychiatric diseases. He reports no conflict of interest with this publication. Michael Paulzen received speaker’s fees from Neuraxpharm (Langenfeld, Germany) and Lundbeck. He reports no conflicts of interest with this publication. Maxim Kuzin received travel grants from Sunovion Pharmaceutical (Basel, Switzerland) and Otsuka Pharmaceutical (Glattbrugg, Switzerland). He also received a travel grant, and participated and obtained a grant on the speaker’s board of Lundbeck (Zurich, Switzerland). Schoretsanitis Georgios has no conflicts of interest that are directly relevant to the content of this article.

: The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. All procedures involving human subjects/patients were approved by the local regulatory authority.

: No informed consent was required for this type of research.

: Not applicable.

: The original data set is available from the Department of Psychiatry and Psychotherapy and Department of Pharmacology and Toxicology, University of Regensburg ().

: Not applicable.

: Participated in research design: GS, JMK, MK, MP, CH, EH. Performed data analysis: GS, MK. Wrote or contributed to the writing of the manuscript: JMK, MK, GS, MP, CH, EH.